{
  "ticker": "TTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963015",
  "id": "02963015",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250627",
  "time": "1458",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l5zqx2d1h6w3.pdf",
  "summary": "- **Type**: Supplementary Prospectus for Capital Raising (original dated 4 June 2025).  \n- **Key Amendments**:  \n  - **Risk Clarification**: Added disclaimer that total addressable market (TAM) of US$6.8B is an estimate only (Section 3.2).  \n  - **Going Concern Risk**: Auditor issued an unqualified opinion with material uncertainty on going concern; no revenue generated to date (Section 3.2).  \n  - **Product Status**: All products under development are not yet commercialized; timelines in Section 2.10 (Sections 3.4\u20133.6).  \n  - **Commercial Strategy**: Details added on partnerships (e.g., Henry Schein for dental applications, Tutelix for urology) (Section 3.5).  \n\n- **No Investor Action Required**: No material adverse changes; no applications processed yet.  \n\n- **Note**: No capital raising details (e.g., amount, dates) in this supplementary document; refer to original prospectus.  \n\n*Brevity prioritized; omitted non-material legal/consent details.*",
  "usage": {
    "prompt_tokens": 2748,
    "completion_tokens": 231,
    "total_tokens": 2979,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-27T05:16:44.060872"
}